Falsified Medical Product Alert N°2/2025
HEALMOXY (amoxicillin) Capsules 500mg: falsified product alert
WHO issued this alert on four falsified batches of HEALMOXY amoxicillin capsules reported to WHO in March 2025. Samples did not contain the stated active ingredient, amoxicillin. At least two products show inconsistent manufacture and expiry date formats. WHO said the product is not effective against bacterial infections, so infections could worsen or spread.1,2
- Issued
- 23 April 2025
- Issued by
- World Health Organization
- Name stated on packaging
- The annex gives MAXHEAL PHARMACEUTICALS (India) Limited as the stated manufacturer. WHO did not report any statement from that company and did not say who made the falsified capsules.
- Countries where detected
- Cameroon, Central African Republic
Batches named in the alert
023011 (stated expiry 18/07/2025, Cameroon), 023011 (stated expiry 10/01/2027, Cameroon), H02605 (stated expiry 02/27, Cameroon), H026051 (stated expiry 01/26, Central African Republic)
Advice as stated
Do not use the listed products. Obtain medicines only from authorised or licensed suppliers. Report adverse events, lack of effect or suspected falsification to the national regulatory authority or pharmacovigilance centre.
Names printed on falsified products are not evidence that the named company made them. Where WHO or a regulator reports the genuine manufacturer's statement, it is shown.
Sources
- World Health Organization, Medical Product Alert N°2/2025: Falsified HEALMOXY (Amoxicillin) Capsules 500mg (23 April 2025)
- World Health Organization, Medical Product Alert N°2/2025: annex (PDF) (23 April 2025)